Shell Asset Management CO Roivant Sciences Ltd. Transaction History
Shell Asset Management CO
- $996 Million
- Q3 2025
A detailed history of Shell Asset Management CO transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Shell Asset Management CO holds 5,239 shares of ROIV stock, worth $108,028. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,239
Previous 12,934
59.49%
Holding current value
$108,028
Previous $146,000
45.89%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ROIV
# of Institutions
360Shares Held
455MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$1.24 Billion5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$922 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$800 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$729 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$706 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.5B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...